✦ LIBER ✦

Enhanced Immunogenicity of Recombinant Hepatitis B Vaccine in Exposed Family Contacts of Chronic Liver Disease Patients

✍ Scribed by V. Thakur, R. C. Guptan, S. F. Basi,

Book ID: 125814498
Publisher: Informa plc
Year: 2001
Tongue: English
Weight: 112 KB
Volume: 33
Category: Article
ISSN: 0036-5548
DOI: 10.1080/00365540110026683

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Decreased immunogenicity of recombinant

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C

✍ Marcus Wiedmann; Uwe G. Liebert; Ute Oesen; Heiner Porst; Manfred Wiese; Sabine 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Immunogenicity of recombinant hepatitis

Immunogenicity of recombinant hepatitis B vaccine in dialysis patients

✍ Jilg, W.; Schmidt, M.; Weinel, B.; Küttler, Th.; Brass, H.; Bommer, J.; Müller, 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Hepatitis B vaccination of patients with

Hepatitis B vaccination of patients with chronic liver disease

✍ Keeffe, Emmet B. ;Krause, David S. 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 29 KB 👁 1 views

De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and economic costs. Althoug

CpG 7909 enhances immunogenicity of reco

CpG 7909 enhances immunogenicity of recombinant hepatitis B vaccine in patients with HIV infection

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec